Technical Analysis for ENZ - Enzo Biochem, Inc.

Grade Last Price % Change Price Change
grade F 4.09 -5.76% -0.25
ENZ closed down 5.76 percent on Friday, September 21, 2018, on 4.79 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Earnings due: Sep 26

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical ENZ trend table...

Date Alert Name Type % Chg
Sep 21 MACD Bearish Centerline Cross Bearish 0.00%
Sep 21 Volume Surge Other 0.00%
Sep 21 Below Lower BB Weakness 0.00%
Sep 21 Down 3 Days in a Row Weakness 0.00%
Sep 21 Down 4 Days in a Row Weakness 0.00%
Sep 21 Down 5 Days in a Row Weakness 0.00%
Sep 21 Lower Bollinger Band Touch Weakness 0.00%
Sep 21 Oversold Stochastic Weakness 0.00%
Sep 20 Stochastic Reached Oversold Weakness -5.76%
Sep 20 Down 3 Days in a Row Weakness -5.76%

Older signals for ENZ ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Enzo Biochem, Inc., an integrated life sciences and biotechnology company, engages in the research, development, manufacture, and marketing of diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. The company operates in three segments: Clinical Labs, Life Sciences, and Therapeutics. The Clinical Labs segment offers routine and esoteric clinical laboratory tests or procedures used in general patient care by physicians to establish or support a diagnosis, monitor treatment or medication, and search for an otherwise undiagnosed condition. This segment operates a full-service clinical laboratory, a network of approximately 30 patient service centers, a laboratory, and a full-service phlebotomy and in-house logistics department. The Life Sciences segment manufactures, develops, and markets products and tools to life sciences, drug development, and clinical research customers. It provides proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which offer tools for target identification/validation, high content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis to life science researchers. This segment provides its products to scientific experts primarily in the field of cancer, cardiovascular disease, neurological disorders, diabetes and obesity, endocrine disorders, infectious and autoimmune disease, hepatotoxicity, and renal injury. The Therapeutics segment researches and develops therapeutic drug candidates in the areas of gastrointestinal, infectious, ophthalmic, and metabolic diseases. The company sells its products through its direct sales force; and a network of distributors worldwide. Enzo Biochem, Inc. was founded in 1976 and is headquartered in New York, New York.
Is ENZ a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 11.49
52 Week Low 3.95
Average Volume 125,437
200-Day Moving Average 6.1725
50-Day Moving Average 4.4848
20-Day Moving Average 4.619
10-Day Moving Average 4.61
Average True Range 0.2038
ADX 18.76
+DI 14.2982
-DI 35.1371
Chandelier Exit (Long, 3 ATRs ) 4.3886
Chandelier Exit (Short, 3 ATRs ) 4.6014
Upper Bollinger Band 5.0137
Lower Bollinger Band 4.2243
Percent B (%b) -0.17
BandWidth 17.090279
MACD Line -0.0314
MACD Signal Line 0.029
MACD Histogram -0.0604
Fundamentals Value
Market Cap 190.38 Million
Num Shares 46.5 Million
EPS -0.05
Price-to-Earnings (P/E) Ratio -81.80
Price-to-Sales 4.40
Price-to-Book 5.34
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.68
Resistance 3 (R3) 4.72 4.58 4.58
Resistance 2 (R2) 4.58 4.43 4.55 4.54
Resistance 1 (R1) 4.33 4.34 4.26 4.29 4.51
Pivot Point 4.19 4.19 4.15 4.16 4.19
Support 1 (S1) 3.94 4.04 3.87 3.90 3.67
Support 2 (S2) 3.80 3.95 3.77 3.64
Support 3 (S3) 3.55 3.80 3.60
Support 4 (S4) 3.51